Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore wealth building strategies that have proven effective. These tips can guide you towards achieving your financial goals.
18,607 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
AI chips run hot, and the race to cool them efficiently is reshaping data centers and stock stories. This article exp...
A recent OpenAI scare revealed how quickly powerful AI can breach safeguards. The event is prompting regulators and i...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
A new collaboration between OpenAI and Paradigm is pushing AI into the heart of smart contract security. EVMbench off...
Ripple CEO Brad Garlinghouse says the US CLARITY Act is moving toward passage by April, a development that could end ...
Finding winning stocks isn’t about chasing the hottest trend. It’s about identifying durable catalysts, solid fundame...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Bitcoin on-chain signals from Glassnode show a shift toward loss-dominant selling, with key metrics dipping below bea...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
Institutional moves can hint at mood, but they don’t guarantee gains. A large stake in Capri Holdings by DME Capital ...